Form 8-K - Current report:
SEC Accession No. 0001193125-20-043867
Filing Date
2020-02-21
Accepted
2020-02-20 21:33:02
Documents
2
Period of Report
2020-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d843140d8k.htm 8-K 17683
2 EX-99.1 d843140dex991.htm EX-99.1 59925
  Complete submission text file 0001193125-20-043867.txt   78798
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 20637224
SIC: 2834 Pharmaceutical Preparations